Cargando…
Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non–ST‐Segment Elevation Myocardial Infarction Discharged Without In‐hospital Revascularization
BACKGROUND: While use of P2Y12 receptor inhibitor is recommended by guidelines, few studies have examined its effectiveness among older non–ST‐segment elevation myocardial infarction patients who did not undergo coronary revascularization. METHODS AND RESULTS: We included unrevascularized non–ST‐seg...
Autores principales: | Hess, Connie N., Hellkamp, Anne S., Roe, Matthew T., Thomas, Laine, Scirica, Benjamin M., Peng, S. Andrew, Peterson, Eric D., Wang, Tracy Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943255/ https://www.ncbi.nlm.nih.gov/pubmed/26976877 http://dx.doi.org/10.1161/JAHA.115.002784 |
Ejemplares similares
-
Clopidogrel use After Myocardial Revascularization: Prevalence,
Predictors, and One-Year Survival Rate
por: Prates, Paulo Roberto L., et al.
Publicado: (2016) -
Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status
por: Thomsen, Anna F, et al.
Publicado: (2022) -
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial
por: Lindholm, Daniel, et al.
Publicado: (2014) -
Likelihood of myocardial infarction, revascularization and death following catheterization laboratory activation in patients with vs. without both chest pain and ST elevation
por: Puleo, Peter, et al.
Publicado: (2020) -
Noninitiation of Discharge Medications After Revascularization
por: Medaglio, Dominique, et al.
Publicado: (2020)